Clinically Significant Adverse Reactions: Fulminant hepatitis, hepatic dysfunction and jaundice (less than 0.1%, each).
Since fulminant hepatitis, serious hepatic dysfunction accompanied with marked elevations of AST (GOT), ALT (GPT) and gamma-GTP, etc. and jaundice may occur and some of them were fatal, the patient should be monitored carefully and if any abnormalities are found, discontinue the administration immediately and give appropriate measures.
Other Adverse Reactions: See Table 4.
Click on icon to see table/diagram/imageInform the doctor in case of any adverse reactions related to drug use.
View ADR Reporting Link
Sign Out